High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?

doi:10.1097/LGT.0b013e3181fb46d8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

High-risk HPV DNA testing and HPV-16/18 genotyping: what is the clinical application?

Journal of lower genital tract disease - 1 Jul 2011

Twiggs Leo B, Hopkins Michael

Abstract excerpt

OBJECTIVE: There are currently 2 tests approved for clinical use that nonspecifically detect the presence of multiple oncogenic or high-risk human papillomavirus (HPV) types. One HPV genotyping test is also available for use that specifically detects the presence of high-risk HPV types 16 and 18. The purpose of this review was to evaluate the clinical performance of these HPV DNA tests and the utility of the...

Topics

Cervix Uteri
DNA, Viral
Female
Genotype
Human papillomavirus 16
Human papillomavirus 18
Humans
Molecular Diagnostic Techniques
Papillomavirus Infections
Precancerous Conditions
Sensitivity and Specificity
Uterine Cervical Neoplasms
Vaginal Smears

Source

Open in PubMed

Identifiers

PMID: 21716051
DOI: 10.1097/LGT.0b013e3181fb46d8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics